Clinical Trial

Prognostic Value of Vitamin D and Intact Parathyroid Hormone (iPTH) in Pulmonary Hypertension

Study acronym: NBHAP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this observational study is to analyse the prognostic value of 25(OH)-vitamin D, iPTH and other serum biomarkers in patients with pulmonary hypertension. Serum samples are obtained from the Spanish Biobank of pulmonary hypertension. Clinical data will be collected from the Spanish registries on pulmonary hypertension (REHAP and REHAR).
Trial Details
NCT Number NCT06872710
Lead Sponsor Universidad Complutense de Madrid
Collaborators: Hospital Clinic of Barcelona
Conditions Pulmonary Hypertension
Enrollment 345 participants
Start Date 2025-03-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-12-28 (estimated)
Updated on ClinicalTrials.gov 2025-03-12